avelumab
merck,Pfizer
['blcsm', 'platform', 'bladder', 'oxford bio']
don t miss the #esmo22 presentation on saturday that discusses the use of our episwitch platform to gain insight into antitumor immunity and identifying patients with advanced #bladdercancer that could benefit from checkpoint inhibitors. #blcsm 
Pioneering 3D genomics in health and medicine.